EQRx, Inc.

The International Association for the Study of Lung Cancer’s World Conference on Lung Cancer from 7 to 10 September in San Diego will showcase the increased focus on targeted therapies, including risi

Flagship Pioneering has more than doubled the funding it has raised since 2021 and will direct it toward building more than a dozen companies across human health, artificial intelligence and sustainab

Confirmatory trials of drugs granted accelerated approval should represent the diversity of patients expected to use the drug in the US, the Food and Drug Administration tells sponsors in a new draft

Chinese developers of immune checkpoint inhibitors including PD-1/L1 antibodies are making fresh progress in clinical trials that could pave the way for eventual US regulatory nods in the space of rel